Accessibility Menu
 
Ecs Botanics logo

Ecs Botanics

(ASX) ECS

Current Price$0.01
Market Cap$7.98M
Since IPO (2019)-92%
5 Year-90%
1 Year-55%
1 Month+0%

Ecs Botanics Financials at a Glance

Market Cap

$7.98M

Revenue (TTM)

$39.45M

Net Income (TTM)

$5.90M

EPS (TTM)

$-0.00

P/E Ratio

-1.43

Dividend

$0.00

Beta (Volatility)

-0.14 (Low)

Price

$0.01

Volume

594,542

Open

$0.01

Previous Close

$0.01

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.01

ECS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ecs Botanics

Industry

Pharmaceuticals

CEO

Nan-Maree Schoerie

Headquarters

Launceston, TAS 7302, AU

ECS Financials

Key Financial Metrics (TTM)

Gross Margin

13%

Operating Margin

-32%

Net Income Margin

-22%

Return on Equity

-18%

Return on Capital

-25%

Return on Assets

-14%

Earnings Yield

-69.93%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.98M

Shares Outstanding

1.60B

Volume

594.54K

Short Interest

0.00%

Avg. Volume

1.67M

Financials (TTM)

Gross Profit

$5.63M

Operating Income

$8.63M

EBITDA

$2.22M

Operating Cash Flow

$5.07M

Capital Expenditure

$3.57M

Free Cash Flow

$8.64M

Cash & ST Invst.

$373.60K

Total Debt

$6.88M

Ecs Botanics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$11.34M

+0.5%

Gross Profit

$472.70K

+70.3%

Gross Margin

-4.17%

N/A

Market Cap

$7.98M

N/A

Market Cap/Employee

$36.27K

N/A

Employees

220

N/A

Net Income

$833.56K

-166.8%

EBITDA

$1.78M

-192.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$8.93M

-355.9%

Accounts Receivable

$2.79M

-22.3%

Inventory

$14.89M

+43.9%

Long Term Debt

$7.26M

+1019.2%

Short Term Debt

$2.98M

+728.5%

Return on Assets

-13.97%

N/A

Return on Invested Capital

-24.53%

N/A

Free Cash Flow

$604.20K

-32.7%

Operating Cash Flow

$359.74K

-14.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HIQ.AXHITIQ Limited
$0.01+0.00%
CHM.AXChimeric Therapeutics Limited
$0.00+0.00%
IXC.AXInvex Therapeutics Ltd
$0.09-2.17%
IVX.AXInvion Limited
$0.07-1.47%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.17+0.00%

Questions About ECS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.